PeptidePedia The community reference

Contributions of ParentCatPansy

User contributions·21 logged edits·page 1 of 1

Contributions by ParentCatPansy, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 9,366 edits includes activity predating the current log.

  1. 08:22, 12 May 2026 (diff | hist) Syringe dead space 20,968 ±0 sentence case in headings per PP:MOS
  2. 11:15, 12 Mar 2026 (diff | hist) Talk:Temperature excursion 1,444 +122 /* Should freezing be a separate article? */ reply
  3. 05:41, 23 Dec 2025 (diff | hist) Lixisenatide 4,195 ±0 m rm the equipotency claim — the cited paper does not make it
  4. 16:06, 16 Dec 2025 (diff | hist) Peptide 6,813 ±0 de-duplicate a repeated sentence
  5. 07:33, 10 Dec 2025 (diff | hist) Talk:Karl Fischer titration 1,096 +195 /* Merge proposal: Loss on drying into this article */ reply
  6. 22:31, 8 Dec 2025 (diff | hist) Global access disparity 4,391 ±0 add the cross-link to the insurance article
  7. 04:57, 11 Oct 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 expand §Less common but significant
  8. 09:05, 4 Sep 2025 (diff | hist) Peptide supply chain 8,410 +263 add the light-exposure point for photosensitive material
  9. 00:47, 29 Jun 2025 (diff | hist) SURPASS trial programme 5,078 +604 split the results table so the two doses are separate rows
  10. 12:51, 20 May 2025 (diff | hist) Placebo-adjusted effect 3,893 ±0 expand §How figures are misreported
  11. 03:34, 6 Apr 2025 (diff | hist) Peptide harm reduction 3,438 +118 fix a broken wikilink
  12. 18:49, 22 Mar 2025 (diff | hist) Intention-to-treat analysis 3,822 +27 give the absolute risk difference alongside the relative one
  13. 07:41, 6 Mar 2025 (diff | hist) GLP-1 receptor agonist 9,254 ±0 m ce per PP:MOS
  14. 14:33, 18 Feb 2025 (diff | hist) Talk:GL Biochem (Shanghai) 748 +234 /* Upstream versus retail: is this the same kind of article? */ reply
  15. 12:38, 10 Feb 2025 (diff | hist) Shanghai Sigma-Audley New Material Technology 6,669 +467 m rm the adjective — an organisation article describes, it does not praise
  16. 14:31, 8 Jan 2025 (diff | hist) Talk:Sangon Biotech 611 +214 /* Scope: is this a peptide supplier article at all? */ reply
  17. 06:15, 27 Dec 2024 (diff | hist) International nonproprietary name 2,755 +514 add the peptide length to the infobox
  18. 13:01, 16 Nov 2024 (diff | hist) Dulaglutide 3,106 ±0 rm duplicated pharmacokinetics — the same figures appear in the infobox
  19. 07:50, 16 Nov 2024 (diff | hist) Amylin receptor agonist 2,571 +35 label the animal data as animal data in the sentence, not only in the section heading
  20. 11:38, 16 Oct 2024 (diff | hist) Dual incretin agonist 3,352 +121 move a stray full stop inside the reference
  21. 01:55, 10 Oct 2024 (diff | hist) LEADER trial 2,187 +223 m add the number randomised and the number completing